Need help finding what you are looking for?
Contact Us
PUBLISHER: KBV Research | PRODUCT CODE: 1220016
PUBLISHER: KBV Research | PRODUCT CODE: 1220016
Europe Real World Evidence Solutions Market Size, Share & Industry Trends Analysis Report By Component, By Therapeutic Area, By End-user, By Application, By Country and Growth Forecast, 2022 - 2028
PUBLISHED:
PAGES: 110 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The Europe Real World Evidence Solutions Market would witness market growth of 8.2% CAGR during the forecast period (2022-2028).
The European Medicines Agency has also developed guidelines for RWE studies that mandate risk-benefit data for post-authorization safety investigations. Therefore, it is anticipated that positive government actions will accelerate market expansion. Additionally, an industry alliance to develop and broaden RWE's application encourages market expansion.
Five companies, including Aetion, IQVIA, Tempus, Flatiron Health, and Syapse, cooperated in 2021 for example, to use data from EHRs, insurance claims, and several other sources outside of clinical trials. The coalition will also collaborate with pharmaceutical firms, producers of medical equipment, patient advocacy organizations, and other significant stakeholders.
This is done to encourage broader initiatives centered on the use of RWE, which, according to coalition members, aids providers, developers, and regulators in having a better understanding of the efficacy and safety of medical products. Such advances will help the market facilitate quicker access to innovative treatment alternatives, which will drive growth.
The institute stresses that realizing this vision, rooted in the Network Strategy to 2025, will encourage the creation and patient usage of better medications. Delivering this ambition will depend heavily on developing the Data Analytics and Real World Interrogation Network (DARWIN EU). It will be possible to analyze and access healthcare data from throughout the EU owing to this network. The initiative will begin in early 2022 with the development of a coordination center to onboard data partners and to direct the completion of studies required by medication regulators and, later, also sought by other stakeholders. RCT data is the main factor in initial price, reimbursement, and market access decisions in Germany because it is the sole drug-specific RWE available before market authorization. These strategies, initiatives, and collaborations are driving the growth of Real World Evidence Solutions Market in Europe.
The Germany market dominated the Europe Real World Evidence Solutions Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $4,206.3 million by 2028.The UK market is anticipated to grow at a CAGR of 7.4% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 9% during (2022 - 2028).
Based on Component, the market is segmented into Services and Data Set. Based on Therapeutic Area, the market is segmented into Oncology, Cardiology, Neurology, Diabetes, Respiratory and Others. Based on End-user, the market is segmented into Healthcare Companies, Healthcare Payers, Healthcare Providers and Others. Based on Application, the market is segmented into Drug Development & Approvals, Medical Device Development & Approvals, Reimbursement/Coverage & Regulatory Decision Making and Post Market Safety & Adverse Events Monitoring. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include IBM Corporation, Oracle Corporation, Medpace Holdings, Inc., IQVIA Holdings, Inc., ICON plc, PerkinElmer, Inc., Parexel International Corporation (Phoenix Parentco, Inc.), PPD, Inc. (Thermo Fisher Scientific, Inc.), UnitedHealth Group, Inc. (Optum, Inc.), and Syneos Health, Inc.
Scope of the Study
Market Segments covered in the Report:
By Component
- Services
- Data Set
By Therapeutic Area
- Oncology
- Cardiology
- Neurology
- Diabetes
- Respiratory
- Others
By End-user
- Healthcare Companies
- Healthcare Payers
- Healthcare Providers
- Others
By Application
- Drug Development & Approvals
- Medical Device Development & Approvals
- Reimbursement/Coverage & Regulatory Decision Making
- Post Market Safety & Adverse Events Monitoring
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Companies Profiled
- IBM Corporation
- Oracle Corporation
- Medpace Holdings, Inc.
- IQVIA Holdings, Inc.
- ICON plc
- PerkinElmer, Inc.
- Parexel International Corporation (Phoenix Parentco, Inc.)
- PPD, Inc. (Thermo Fisher Scientific, Inc.)
- UnitedHealth Group, Inc. (Optum, Inc.)
- Syneos Health, Inc.
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Europe Real World Evidence Solutions Market, by Component
- 1.4.2 Europe Real World Evidence Solutions Market, by Therapeutic Area
- 1.4.3 Europe Real World Evidence Solutions Market, by End-user
- 1.4.4 Europe Real World Evidence Solutions Market, by Application
- 1.4.5 Europe Real World Evidence Solutions Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market Overview
- 2.1 Introduction
- 2.1.1 Overview
- 2.1.1.1 Market Scenario and Composition
- 2.1.1 Overview
- 2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Real World Evidence Solutions Market
Chapter 4. Europe Real World Evidence Solutions Market by Component
- 4.1 Europe Services Market by Country
- 4.2 Europe Data Set Market by Country
Chapter 5. Europe Real World Evidence Solutions Market by Therapeutic Area
- 5.1 Europe Oncology Market by Country
- 5.2 Europe Cardiology Market by Country
- 5.3 Europe Neurology Market by Country
- 5.4 Europe Diabetes Market by Country
- 5.5 Europe Respiratory Market by Country
- 5.6 Europe Others Market by Country
Chapter 6. Europe Real World Evidence Solutions Market by End-user
- 6.1 Europe Healthcare Companies Market by Country
- 6.2 Europe Healthcare Payers Market by Country
- 6.3 Europe Healthcare Providers Market by Country
- 6.4 Europe Others Market by Country
Chapter 7. Europe Real World Evidence Solutions Market by Application
- 7.1 Europe Drug Development & Approvals Market by Country
- 7.2 Europe Medical Device Development & Approvals Market by Country
- 7.3 Europe Reimbursement/Coverage & Regulatory Decision Making Market by Country
- 7.4 Europe Post Market Safety & Adverse Events Monitoring Market by Country
Chapter 8. Europe Real World Evidence Solutions Market by Country
- 8.1 Germany Real World Evidence Solutions Market
- 8.1.1 Germany Real World Evidence Solutions Market by Component
- 8.1.2 Germany Real World Evidence Solutions Market by Therapeutic Area
- 8.1.3 Germany Real World Evidence Solutions Market by End-user
- 8.1.4 Germany Real World Evidence Solutions Market by Application
- 8.2 UK Real World Evidence Solutions Market
- 8.2.1 UK Real World Evidence Solutions Market by Component
- 8.2.2 UK Real World Evidence Solutions Market by Therapeutic Area
- 8.2.3 UK Real World Evidence Solutions Market by End-user
- 8.2.4 UK Real World Evidence Solutions Market by Application
- 8.3 France Real World Evidence Solutions Market
- 8.3.1 France Real World Evidence Solutions Market by Component
- 8.3.2 France Real World Evidence Solutions Market by Therapeutic Area
- 8.3.3 France Real World Evidence Solutions Market by End-user
- 8.3.4 France Real World Evidence Solutions Market by Application
- 8.4 Russia Real World Evidence Solutions Market
- 8.4.1 Russia Real World Evidence Solutions Market by Component
- 8.4.2 Russia Real World Evidence Solutions Market by Therapeutic Area
- 8.4.3 Russia Real World Evidence Solutions Market by End-user
- 8.4.4 Russia Real World Evidence Solutions Market by Application
- 8.5 Spain Real World Evidence Solutions Market
- 8.5.1 Spain Real World Evidence Solutions Market by Component
- 8.5.2 Spain Real World Evidence Solutions Market by Therapeutic Area
- 8.5.3 Spain Real World Evidence Solutions Market by End-user
- 8.5.4 Spain Real World Evidence Solutions Market by Application
- 8.6 Italy Real World Evidence Solutions Market
- 8.6.1 Italy Real World Evidence Solutions Market by Component
- 8.6.2 Italy Real World Evidence Solutions Market by Therapeutic Area
- 8.6.3 Italy Real World Evidence Solutions Market by End-user
- 8.6.4 Italy Real World Evidence Solutions Market by Application
- 8.7 Rest of Europe Real World Evidence Solutions Market
- 8.7.1 Rest of Europe Real World Evidence Solutions Market by Component
- 8.7.2 Rest of Europe Real World Evidence Solutions Market by Therapeutic Area
- 8.7.3 Rest of Europe Real World Evidence Solutions Market by End-user
- 8.7.4 Rest of Europe Real World Evidence Solutions Market by Application
Chapter 9. Company Profiles
- 9.1 IBM Corporation
- 9.1.1 Company Overview
- 9.1.2 Financial Analysis
- 9.1.3 Regional & Segmental Analysis
- 9.1.4 Research & Development Expenses
- 9.1.5 Recent strategies and developments:
- 9.1.5.1 Acquisition and Mergers:
- 9.1.6 SWOT Analysis
- 9.2 Oracle Corporation
- 9.2.1 Company Overview
- 9.2.2 Financial Analysis
- 9.2.3 Segmental and Regional Analysis
- 9.2.4 Research & Development Expense
- 9.2.5 SWOT Analysis
- 9.3 PPD, Inc. (Thermo Fisher Scientific, Inc.)
- 9.3.1 Company Overview
- 9.3.2 Financial Analysis
- 9.3.3 Segmental and Regional Analysis
- 9.3.4 Research & Development Expense
- 9.3.5 SWOT Analysis
- 9.4 UnitedHealth Group, Inc. (Optum, Inc.)
- 9.4.1 Company Overview
- 9.4.2 Financial Analysis
- 9.4.3 Segmental Analysis
- 9.5 Syneos Health, Inc.
- 9.5.1 Company Overview
- 9.5.2 Financial Analysis
- 9.5.3 Segmental and Regional Analysis
- 9.5.4 Recent strategies and developments:
- 9.5.4.1 Acquisition and Mergers:
- 9.6 IQVIA Holdings, Inc.
- 9.6.1 Company Overview
- 9.6.2 Financial Analysis
- 9.6.3 Segmental and Regional Analysis
- 9.6.4 Recent strategies and developments:
- 9.6.4.1 Partnerships, Collaborations, and Agreements:
- 9.6.4.2 Acquisition and Mergers:
- 9.7 Medpace Holdings, Inc.
- 9.7.1 Company Overview
- 9.7.2 Financial Analysis
- 9.8 ICON plc
- 9.8.1 Company Overview
- 9.8.2 Financial Analysis
- 9.8.3 Regional Analysis
- 9.8.4 Recent strategies and developments:
- 9.8.4.1 Acquisition and Mergers:
- 9.9 PerkinElmer, Inc.
- 9.9.1 Company Overview
- 9.9.2 Financial Analysis
- 9.9.3 Segmental and Regional Analysis
- 9.9.4 Research & Development Expense
- 9.9.5 Recent strategies and developments:
- 9.9.5.1 Product Launches and Product Expansions:
- 9.10. Parexel International Corporation (Phoenix Parentco, Inc.)
- 9.10.1 Company Overview
- 9.10.2 Recent strategies and developments:
- 9.10.2.1 Partnerships, Collaborations, and Agreements:
LIST OF TABLES
- TABLE 1 Europe Real World Evidence Solutions Market, 2018 - 2021, USD Million
- TABLE 2 Europe Real World Evidence Solutions Market, 2022 - 2028, USD Million
- TABLE 3 Europe Real World Evidence Solutions Market by Component, 2018 - 2021, USD Million
- TABLE 4 Europe Real World Evidence Solutions Market by Component, 2022 - 2028, USD Million
- TABLE 5 Europe Services Market by Country, 2018 - 2021, USD Million
- TABLE 6 Europe Services Market by Country, 2022 - 2028, USD Million
- TABLE 7 Europe Data Set Market by Country, 2018 - 2021, USD Million
- TABLE 8 Europe Data Set Market by Country, 2022 - 2028, USD Million
- TABLE 9 Europe Real World Evidence Solutions Market by Therapeutic Area, 2018 - 2021, USD Million
- TABLE 10 Europe Real World Evidence Solutions Market by Therapeutic Area, 2022 - 2028, USD Million
- TABLE 11 Europe Oncology Market by Country, 2018 - 2021, USD Million
- TABLE 12 Europe Oncology Market by Country, 2022 - 2028, USD Million
- TABLE 13 Europe Cardiology Market by Country, 2018 - 2021, USD Million
- TABLE 14 Europe Cardiology Market by Country, 2022 - 2028, USD Million
- TABLE 15 Europe Neurology Market by Country, 2018 - 2021, USD Million
- TABLE 16 Europe Neurology Market by Country, 2022 - 2028, USD Million
- TABLE 17 Europe Diabetes Market by Country, 2018 - 2021, USD Million
- TABLE 18 Europe Diabetes Market by Country, 2022 - 2028, USD Million
- TABLE 19 Europe Respiratory Market by Country, 2018 - 2021, USD Million
- TABLE 20 Europe Respiratory Market by Country, 2022 - 2028, USD Million
- TABLE 21 Europe Others Market by Country, 2018 - 2021, USD Million
- TABLE 22 Europe Others Market by Country, 2022 - 2028, USD Million
- TABLE 23 Europe Real World Evidence Solutions Market by End-user, 2018 - 2021, USD Million
- TABLE 24 Europe Real World Evidence Solutions Market by End-user, 2022 - 2028, USD Million
- TABLE 25 Europe Healthcare Companies Market by Country, 2018 - 2021, USD Million
- TABLE 26 Europe Healthcare Companies Market by Country, 2022 - 2028, USD Million
- TABLE 27 Europe Healthcare Payers Market by Country, 2018 - 2021, USD Million
- TABLE 28 Europe Healthcare Payers Market by Country, 2022 - 2028, USD Million
- TABLE 29 Europe Healthcare Providers Market by Country, 2018 - 2021, USD Million
- TABLE 30 Europe Healthcare Providers Market by Country, 2022 - 2028, USD Million
- TABLE 31 Europe Others Market by Country, 2018 - 2021, USD Million
- TABLE 32 Europe Others Market by Country, 2022 - 2028, USD Million
- TABLE 33 Europe Real World Evidence Solutions Market by Application, 2018 - 2021, USD Million
- TABLE 34 Europe Real World Evidence Solutions Market by Application, 2022 - 2028, USD Million
- TABLE 35 Europe Drug Development & Approvals Market by Country, 2018 - 2021, USD Million
- TABLE 36 Europe Drug Development & Approvals Market by Country, 2022 - 2028, USD Million
- TABLE 37 Europe Medical Device Development & Approvals Market by Country, 2018 - 2021, USD Million
- TABLE 38 Europe Medical Device Development & Approvals Market by Country, 2022 - 2028, USD Million
- TABLE 39 Europe Reimbursement/Coverage & Regulatory Decision Making Market by Country, 2018 - 2021, USD Million
- TABLE 40 Europe Reimbursement/Coverage & Regulatory Decision Making Market by Country, 2022 - 2028, USD Million
- TABLE 41 Europe Post Market Safety & Adverse Events Monitoring Market by Country, 2018 - 2021, USD Million
- TABLE 42 Europe Post Market Safety & Adverse Events Monitoring Market by Country, 2022 - 2028, USD Million
- TABLE 43 Europe Real World Evidence Solutions Market by Country, 2018 - 2021, USD Million
- TABLE 44 Europe Real World Evidence Solutions Market by Country, 2022 - 2028, USD Million
- TABLE 45 Germany Real World Evidence Solutions Market, 2018 - 2021, USD Million
- TABLE 46 Germany Real World Evidence Solutions Market, 2022 - 2028, USD Million
- TABLE 47 Germany Real World Evidence Solutions Market by Component, 2018 - 2021, USD Million
- TABLE 48 Germany Real World Evidence Solutions Market by Component, 2022 - 2028, USD Million
- TABLE 49 Germany Real World Evidence Solutions Market by Therapeutic Area, 2018 - 2021, USD Million
- TABLE 50 Germany Real World Evidence Solutions Market by Therapeutic Area, 2022 - 2028, USD Million
- TABLE 51 Germany Real World Evidence Solutions Market by End-user, 2018 - 2021, USD Million
- TABLE 52 Germany Real World Evidence Solutions Market by End-user, 2022 - 2028, USD Million
- TABLE 53 Germany Real World Evidence Solutions Market by Application, 2018 - 2021, USD Million
- TABLE 54 Germany Real World Evidence Solutions Market by Application, 2022 - 2028, USD Million
- TABLE 55 UK Real World Evidence Solutions Market, 2018 - 2021, USD Million
- TABLE 56 UK Real World Evidence Solutions Market, 2022 - 2028, USD Million
- TABLE 57 UK Real World Evidence Solutions Market by Component, 2018 - 2021, USD Million
- TABLE 58 UK Real World Evidence Solutions Market by Component, 2022 - 2028, USD Million
- TABLE 59 UK Real World Evidence Solutions Market by Therapeutic Area, 2018 - 2021, USD Million
- TABLE 60 UK Real World Evidence Solutions Market by Therapeutic Area, 2022 - 2028, USD Million
- TABLE 61 UK Real World Evidence Solutions Market by End-user, 2018 - 2021, USD Million
- TABLE 62 UK Real World Evidence Solutions Market by End-user, 2022 - 2028, USD Million
- TABLE 63 UK Real World Evidence Solutions Market by Application, 2018 - 2021, USD Million
- TABLE 64 UK Real World Evidence Solutions Market by Application, 2022 - 2028, USD Million
- TABLE 65 France Real World Evidence Solutions Market, 2018 - 2021, USD Million
- TABLE 66 France Real World Evidence Solutions Market, 2022 - 2028, USD Million
- TABLE 67 France Real World Evidence Solutions Market by Component, 2018 - 2021, USD Million
- TABLE 68 France Real World Evidence Solutions Market by Component, 2022 - 2028, USD Million
- TABLE 69 France Real World Evidence Solutions Market by Therapeutic Area, 2018 - 2021, USD Million
- TABLE 70 France Real World Evidence Solutions Market by Therapeutic Area, 2022 - 2028, USD Million
- TABLE 71 France Real World Evidence Solutions Market by End-user, 2018 - 2021, USD Million
- TABLE 72 France Real World Evidence Solutions Market by End-user, 2022 - 2028, USD Million
- TABLE 73 France Real World Evidence Solutions Market by Application, 2018 - 2021, USD Million
- TABLE 74 France Real World Evidence Solutions Market by Application, 2022 - 2028, USD Million
- TABLE 75 Russia Real World Evidence Solutions Market, 2018 - 2021, USD Million
- TABLE 76 Russia Real World Evidence Solutions Market, 2022 - 2028, USD Million
- TABLE 77 Russia Real World Evidence Solutions Market by Component, 2018 - 2021, USD Million
- TABLE 78 Russia Real World Evidence Solutions Market by Component, 2022 - 2028, USD Million
- TABLE 79 Russia Real World Evidence Solutions Market by Therapeutic Area, 2018 - 2021, USD Million
- TABLE 80 Russia Real World Evidence Solutions Market by Therapeutic Area, 2022 - 2028, USD Million
- TABLE 81 Russia Real World Evidence Solutions Market by End-user, 2018 - 2021, USD Million
- TABLE 82 Russia Real World Evidence Solutions Market by End-user, 2022 - 2028, USD Million
- TABLE 83 Russia Real World Evidence Solutions Market by Application, 2018 - 2021, USD Million
- TABLE 84 Russia Real World Evidence Solutions Market by Application, 2022 - 2028, USD Million
- TABLE 85 Spain Real World Evidence Solutions Market, 2018 - 2021, USD Million
- TABLE 86 Spain Real World Evidence Solutions Market, 2022 - 2028, USD Million
- TABLE 87 Spain Real World Evidence Solutions Market by Component, 2018 - 2021, USD Million
- TABLE 88 Spain Real World Evidence Solutions Market by Component, 2022 - 2028, USD Million
- TABLE 89 Spain Real World Evidence Solutions Market by Therapeutic Area, 2018 - 2021, USD Million
- TABLE 90 Spain Real World Evidence Solutions Market by Therapeutic Area, 2022 - 2028, USD Million
- TABLE 91 Spain Real World Evidence Solutions Market by End-user, 2018 - 2021, USD Million
- TABLE 92 Spain Real World Evidence Solutions Market by End-user, 2022 - 2028, USD Million
- TABLE 93 Spain Real World Evidence Solutions Market by Application, 2018 - 2021, USD Million
- TABLE 94 Spain Real World Evidence Solutions Market by Application, 2022 - 2028, USD Million
- TABLE 95 Italy Real World Evidence Solutions Market, 2018 - 2021, USD Million
- TABLE 96 Italy Real World Evidence Solutions Market, 2022 - 2028, USD Million
- TABLE 97 Italy Real World Evidence Solutions Market by Component, 2018 - 2021, USD Million
- TABLE 98 Italy Real World Evidence Solutions Market by Component, 2022 - 2028, USD Million
- TABLE 99 Italy Real World Evidence Solutions Market by Therapeutic Area, 2018 - 2021, USD Million
- TABLE 100 Italy Real World Evidence Solutions Market by Therapeutic Area, 2022 - 2028, USD Million
- TABLE 101 Italy Real World Evidence Solutions Market by End-user, 2018 - 2021, USD Million
- TABLE 102 Italy Real World Evidence Solutions Market by End-user, 2022 - 2028, USD Million
- TABLE 103 Italy Real World Evidence Solutions Market by Application, 2018 - 2021, USD Million
- TABLE 104 Italy Real World Evidence Solutions Market by Application, 2022 - 2028, USD Million
- TABLE 105 Rest of Europe Real World Evidence Solutions Market, 2018 - 2021, USD Million
- TABLE 106 Rest of Europe Real World Evidence Solutions Market, 2022 - 2028, USD Million
- TABLE 107 Rest of Europe Real World Evidence Solutions Market by Component, 2018 - 2021, USD Million
- TABLE 108 Rest of Europe Real World Evidence Solutions Market by Component, 2022 - 2028, USD Million
- TABLE 109 Rest of Europe Real World Evidence Solutions Market by Therapeutic Area, 2018 - 2021, USD Million
- TABLE 110 Rest of Europe Real World Evidence Solutions Market by Therapeutic Area, 2022 - 2028, USD Million
- TABLE 111 Rest of Europe Real World Evidence Solutions Market by End-user, 2018 - 2021, USD Million
- TABLE 112 Rest of Europe Real World Evidence Solutions Market by End-user, 2022 - 2028, USD Million
- TABLE 113 Rest of Europe Real World Evidence Solutions Market by Application, 2018 - 2021, USD Million
- TABLE 114 Rest of Europe Real World Evidence Solutions Market by Application, 2022 - 2028, USD Million
- TABLE 115 Key information - IBM Corporation
- TABLE 116 Key Information - Oracle Corporation
- TABLE 117 Key Information - PPD, Inc.
- TABLE 118 Key Information - UnitedHealth Group, Inc.
- TABLE 119 Key Information - Syneos Health, Inc.
- TABLE 120 Key information - IQVIA Holdings, Inc.
- TABLE 121 key Information - Medpace Holdings, Inc.
- TABLE 122 key Information - PerkinElmer, Inc.
- TABLE 123 Key Information - PAREXEL International Corporation
List of Figures
- FIG 1 Methodology for the research
- FIG 2 Swot analysis: IBM Corporation
- FIG 3 SWOT analysis: Oracle Corporation
- FIG 4 Swot analysis: thermo fisher scientific, inc.
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.